This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Katholieke Universiteit Leuven, University of Ghent, Vib Vzw. Active years: 2017-2021.
Location History:
- Brussels, BE (2017)
- Linden, BE (2021)
Company Filing History:
2 out of 630 
2 out of 505 
2 out of 237 
Years Active: 2017-2021
Title: Eleonora Leucci: Innovator in Melanoma Research
Introduction
Eleonora Leucci is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of cancer research, particularly in the treatment of melanoma. With two patents to her name, her work focuses on innovative therapeutic strategies that target specific molecular pathways in cancer cells.
Latest Patents
Leucci's latest patents revolve around the inhibition of a long non-coding RNA (lncRNA) for the treatment of melanoma. This research has revealed that a particular lncRNA is specifically up-regulated in melanoma cells compared to normal melanocytes. By inhibiting this lncRNA, Leucci's work demonstrates the potential to induce apoptosis in melanoma cells, offering a novel therapeutic strategy for treating this aggressive form of skin cancer.
Career Highlights
Throughout her career, Eleonora Leucci has worked with notable institutions, including Vib Vzw and Katholieke Universiteit Leuven, also known as KU Leuven R&D. Her research has garnered attention for its innovative approach to cancer treatment, positioning her as a key figure in the field.
Collaborations
Leucci has collaborated with esteemed colleagues such as Jean-Christophe Marine and Joke Vandesompele. These partnerships have further enhanced her research and contributed to the advancement of knowledge in melanoma treatment.
Conclusion
Eleonora Leucci's contributions to melanoma research through her innovative patents highlight her role as a leading inventor in the field. Her work not only advances scientific understanding but also opens new avenues for therapeutic interventions in cancer treatment.